Abstract
An overview of current options for the diagnosis and treatment of thyroid carcinomas and microcarcinomas is given. The need for lifelong monitoring of patients by determining the levels of tumor markers and using imaging methods is emphasized.
Exogenous stimulation of TSH by recombinant human TSH is newly used as an alternative to achieve hypothyroidism.